| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |